Hematopoiesis is sustained by a population of stem cells that can both replicate and differentiate. Pluripotent hematopoietic stem cells are the most primitive stem cells and are central to hematopoietic development. These cells can divide to make daughter cells or can differentiate through a hierarchial pathway of increasingly committed stem cells to mature blood cells. The ability of each stem cell to proliferate and differentiate is termed its developmental potential. During fetal development hematopoietic stem cells migrate from the yolk sac to fetal liver and ultimately to the bone marrow. The hematopoietic progeny of these cells colonize multiple organs during fetal development including spleen, liver, thymus, lung and brain. There is considerable evidence to suggest that the biological properties of hematopoietic cells resident in the yolk sac or fetal liver may differ from those in adult animals. Some but not all previous studies have suggested that the proliferative and self-renewal capacity of fetal hematopoietic stem cells resident in the liver are superior to those in the medullary cavity of the adult animal. However, due to the inability to identify stem cells or the progeny of individual stem cells, it has not been possible to characterize the developmental potential of individual hematopoietic stem cell clones during normal fetal development. The general goals of this proposal are: 1) To define the developmental potential of fetal hematopoietic stem cells resident in the fetal liver; 2) To evaluate the cellular, organ and clonal distribution of the hematopoietic progeny of these cells in selected tissues of neonatal and adult animals. We will achieve these goals by introducing foreign genes in utero into hematopoietic stem cells of rat fetuses by using retroviral vectors. Hematopoietic stem cells are actively proliferating, and are resident in high concentrations in the liver of midgestation rats, and are thus an attractive target for retroviral gene transfer. We have previously demonstrated that primitive hematopoietic precursors can be retrovirally transduced by direct injection of provirus in utero into the liver of midgestation rats. This unique approach to transducing hematopoietic cells in vivo will enhance the study of fetal hematopoietic development and may provide information relative to the potential correction of genetic diseases affecting hematopoietic cells and selected metabolic disorders in utero.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL002721-02
Application #
3083141
Study Section
Special Emphasis Panel (SRC (FB))
Project Start
1992-04-01
Project End
1997-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Onyia, J E; Clapp, D W; Long, H et al. (1998) Osteoprogenitor cells as targets for ex vivo gene transfer. J Bone Miner Res 13:20-30
Bernstein, J; Boyle, D W; Srour, E F et al. (1997) Variation in long-term engraftment of a large consecutive series of lambs transplanted in utero with human hematopoietic cells. Biol Blood Marrow Transplant 3:247-54
Freie, B W; Dutt, P; Clapp, D W (1996) Correction of Fanconi anemia type C phenotypic abnormalities using a clinically suitable retroviral vector infection protocol. Cell Transplant 5:385-93
Haneline, L S; Marshall, K P; Clapp, D W (1996) The highest concentration of primitive hematopoietic progenitor cells in cord blood is found in extremely premature infants. Pediatr Res 39:820-5
Bollag, G; Clapp, D W; Shih, S et al. (1996) Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 12:144-8
Clapp, D W; Freie, B; Lee, W H et al. (1995) Molecular evidence that in situ-transduced fetal liver hematopoietic stem/progenitor cells give rise to medullary hematopoiesis in adult rats. Blood 86:2113-22
Clapp, D W; Williams, D A (1995) The use of umbilical cord blood as a cellular source for correction of genetic diseases affecting the hematopoietic system. Stem Cells 13:613-21
Traycoff, C M; Abboud, M R; Laver, J et al. (1994) Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Exp Hematol 22:1264-72